DELTA ASSET MANAGEMENT LLC/TN - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 34 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DELTA ASSET MANAGEMENT LLC/TN ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q4 2018$72,000
+5.9%
12,0000.0%0.01%
+22.2%
Q3 2018$68,000
+1.5%
12,000
+9.1%
0.01%
-10.0%
Q2 2018$67,000
-8.2%
11,0000.0%0.01%
-9.1%
Q1 2018$73,000
-9.9%
11,0000.0%0.01%0.0%
Q4 2017$81,000
-4.7%
11,000
-8.3%
0.01%
-15.4%
Q3 2017$85,000
+1.2%
12,0000.0%0.01%0.0%
Q2 2017$84,000
+1.2%
12,0000.0%0.01%0.0%
Q1 2017$83,000
+23.9%
12,0000.0%0.01%
+18.2%
Q4 2016$67,000
+11.7%
12,0000.0%0.01%
+10.0%
Q3 2016$60,000
+9.1%
12,0000.0%0.01%0.0%
Q2 2016$55,000
+3.8%
12,0000.0%0.01%
+11.1%
Q1 2016$53,000
-15.9%
12,0000.0%0.01%
-25.0%
Q4 2015$63,000
-8.7%
12,0000.0%0.01%
-14.3%
Q3 2015$69,000
-12.7%
12,000
+9.1%
0.01%
-6.7%
Q2 2015$79,000
+8.2%
11,0000.0%0.02%
+7.1%
Q1 2015$73,000
+10.6%
11,0000.0%0.01%
+7.7%
Q4 2014$66,000
+22.2%
11,0000.0%0.01%
+18.2%
Q3 2014$54,000
+8.0%
11,0000.0%0.01%
+10.0%
Q2 2014$50,0000.0%11,0000.0%0.01%
-9.1%
Q1 2014$50,000
-10.7%
11,0000.0%0.01%
-8.3%
Q4 2013$56,000
+12.0%
11,0000.0%0.01%0.0%
Q3 2013$50,000
-10.7%
11,0000.0%0.01%
-14.3%
Q2 2013$56,00011,0000.01%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q2 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 896,170$4,615,0003.22%
Ariel Investments 1,010,220$5,203,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 183,000$942,0000.01%
Anfield Capital Management, LLC 4,530$23,0000.01%
Financial Gravity Asset Management, Inc. 2,000$10,0000.01%
Oakworth Capital, Inc. 3,052$16,0000.00%
BAILARD, INC. 11,816$61,0000.00%
DIMENSIONAL FUND ADVISORS LP 860,319$4,431,0000.00%
Renaissance Technologies 469,338$2,417,0000.00%
ACADIAN ASSET MANAGEMENT LLC 98,192$506,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders